Dare Bioscience, Inc. 8-K

What Happened Daré Bioscience, Inc. (DARE) filed a Form 8‑K on June 22, 2026 (Item 7.01) disclosing a corporate presentation dated June 22, 2026. The presentation was furnished as Exhibit 99.1 and the company stated it will use the presentation and its contents in meetings with securities market participants beginning June 22, 2026. Daré plans to post the presentation on its Investors website under “Presentations, Events & Webcasts.” The company also noted that information on its website is not incorporated by reference into the 8‑K.

Key Details

• Filing type: Regulation FD disclosure (Item 7.01) furnished via Form 8‑K on June 22, 2026.
• Exhibit: 99.1 — Daré Bioscience corporate presentation dated June 22, 2026.
• Availability: Presentation to be posted on Daré’s Investors site (https://ir.darebioscience.com) under “Presentations, Events & Webcasts.”
• Interactive data: Cover Page Interactive Data File included as Exhibit 104 in the filing.

Why It Matters This 8‑K makes Daré’s latest corporate presentation formally available to the public and confirms the company will present the same materials to market participants, helping ensure consistent, fair disclosure under Regulation FD. Investors should review the posted presentation for the company’s current messaging on strategy, product development and corporate priorities; the filing itself does not incorporate website content by reference.